Transmembrane and soluble isoforms of heparin-binding epidermal growth factor-like growth factor regulate distinct processes in the pancreas.

BACKGROUND & AIMS Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is produced as a type-I, single-pass transmembrane protein that can be cleaved to release a diffusible peptide. HB-EGF, often overexpressed in damaged or diseased epithelium, is normally expressed in pancreatic islets, but its function is not understood. METHODS To understand the function of each isoform of HB-EGF, we made transgenes expressing either a constitutively transmembrane or a constitutively secreted protein. RESULTS The transmembrane isoform was not an inert precursor protein, but a functional molecule, downregulating the glucose-sensing apparatus of pancreatic islets. Conversely, the secreted form of HB-EGF improved islet function, but had severe fibrotic and neoplastic effects on surrounding tissues. Each isoform had a more severe phenotype than that of full-length HB-EGF, even though the full-length protein was efficiently cleaved, thus producing both isoforms, suggesting that a level of regulation was lost by separating the isoforms. CONCLUSIONS This work demonstrates that islet function depends on the ratio of cleaved to uncleaved HB-EGF and that the transmembrane intermediate, while deleterious to islet function, is necessary to restrict action of soluble HB-EGF away from surrounding tissue.

[1]  Sam W. Lee,et al.  Membrane-bound heparin-binding epidermal growth factor like growth factor regulates E-cadherin expression in pancreatic carcinoma cells. , 2007, Cancer research.

[2]  R. Schmid,et al.  Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. , 2007, Cancer cell.

[3]  P. Berggren,et al.  Downregulation of EGF Receptor Signaling in Pancreatic Islets Causes Diabetes Due to Impaired Postnatal β-Cell Growth , 2006, Diabetes.

[4]  S. Leach,et al.  Pancreatic epithelial plasticity mediated by acinar cell transdifferentiation and generation of nestin-positive intermediates , 2005, Development.

[5]  Robert Jaster,et al.  Molecular regulation of pancreatic stellate cell function , 2004, Molecular Cancer.

[6]  J. Louet,et al.  Antidiabetic actions of estrogen: Insight from human and genetic mouse models , 2004, Current atherosclerosis reports.

[7]  R. Harris,et al.  Membrane-associated HB-EGF modulates HGF-induced cellular responses in MDCK cells , 2004, Journal of Cell Science.

[8]  Y. Kaneda,et al.  Mice with defects in HB-EGF ectodomain shedding show severe developmental abnormalities , 2003, The Journal of cell biology.

[9]  D. Longnecker,et al.  Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. , 2003, Cancer research.

[10]  M. Washington,et al.  Overexpression of heparin-binding EGF-like growth factor in mouse pancreas results in fibrosis and epithelial metaplasia. , 2003, Gastroenterology.

[11]  Y. Mori,et al.  Involvement of HB-EGF and EGF receptor transactivation in TGF-beta-mediated fibronectin expression in mesangial cells. , 2002, Kidney international.

[12]  S. Leach,et al.  Transgenic overexpression of amphiregulin induces a mitogenic response selectively in pancreatic duct cells. , 2002, Gastroenterology.

[13]  C. Wright,et al.  Regulatory regions driving developmental and tissue-specific expression of the essential pancreatic gene pdx1. , 2001, Developmental biology.

[14]  R. Burcelin,et al.  Transgenic Reexpression of GLUT1 or GLUT2 in Pancreatic β Cells Rescues GLUT2-null Mice from Early Death and Restores Normal Glucose-stimulated Insulin Secretion* , 2000, The Journal of Biological Chemistry.

[15]  Y. Matsuzawa,et al.  Immunohistochemical localization of betacellulin, a new member of the EGF family, in normal human pancreas and islet tumor cells. , 1999, Endocrine journal.

[16]  E. Mekada,et al.  Contact-dependent Growth Inhibition and Apoptosis of Epidermal Growth Factor (EGF) Receptor-expressing Cells by the Membrane-anchored Form of Heparin-binding EGF-like Growth Factor* , 1999, The Journal of Biological Chemistry.

[17]  N. Sarvetnick,et al.  Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes. , 1999, The Journal of endocrinology.

[18]  R. Schmid,et al.  Malignant transformation of duct-like cells originating from acini in transforming growth factor transgenic mice. , 1998, Gastroenterology.

[19]  H. Kaneto,et al.  Expression of Heparin-binding Epidermal Growth Factor-like Growth Factor during Pancreas Development , 1997, The Journal of Biological Chemistry.

[20]  E. Mekada,et al.  Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites , 1995, The Journal of cell biology.

[21]  M. Klagsbrun,et al.  The membrane protein CD9/DRAP 27 potentiates the juxtacrine growth factor activity of the membrane-anchored heparin-binding EGF-like growth factor , 1995, The Journal of cell biology.

[22]  G. Merlino,et al.  Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor alpha. , 1992, Gastroenterology.

[23]  R. Palmiter,et al.  Overexpression of TGFα in transgenic mice: Induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast , 1990, Cell.

[24]  A. Ullrich,et al.  EGF receptor transactivation by G-protein-coupled receptors requires metalloproteinase cleavage of proHB-EGF , 1999, Nature.

[25]  M. Birnbaum,et al.  Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2 , 1998, Nature Genetics.